Prosecution Insights
Last updated: October 04, 2026

Miami University

Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics

5 pending office actions • 4 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

Miami University maintains 5 pending office actions in the Biotechnology & Pharmaceuticals technology area. These filings are distributed across 4 distinct art units, showing that the university's research output spans several specialized groups within the patent office. The involvement of 4 distinct art units indicates a breadth of technical subject matter within the life sciences sector for the institution's current applications.

The portfolio is handled by 5 distinct examiners, matching the total count of pending office actions. JOEL LAMPRECHT is the busiest examiner with 1 pending office action. This indicates that no single examiner is managing multiple pending matters, spreading the prosecution workload across the various officials. Because the number of examiners equals the number of pending office actions, the university interacts with a different official for every active case in this set. This distribution may result in varied prosecution experiences across the portfolio.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

5
Total Pending OAs
4
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
1
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (40%)
3
Medium (60%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (40%)
§102 only1 (20%)
Multi-statute (no §101)2 (40%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
60% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
20% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
20% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LAMPRECHT, JOEL 1 81.4% +16.8%
MOEHLMAN, ANDREW TERRY 1 66.3% +61.0%
CHATTERJEE, JAYANTA 1 45.5% +80.0%
WRIGHT, ANDREW RUSSELL 1 65.5% +41.7%
BATES, KEENAN ALEXANDER 1 45.5% +79.5%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18888800 DIGITAL AUTOCORRELATOR LAMPRECHT, JOEL —
18706982 METHODS FOR THE PRODUCTION OF TRYPTOPHANS, TRYPTAMINES, INTERMEDIATES, SIDE PRODUCTS AND DERIVATIVES MOEHLMAN, ANDREW TERRY —

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18400586 COMPOSITIONS AND METHODS OF ENHANCING PHOTOSYNTHESIS CHATTERJEE, JAYANTA 15d overdue
18161467 CELLULAR REPROGRAMMING OF HUMAN ADIPOCYTES BATES, KEENAN ALEXANDER 79d
18888800 DIGITAL AUTOCORRELATOR LAMPRECHT, JOEL —
18706982 METHODS FOR THE PRODUCTION OF TRYPTOPHANS, TRYPTAMINES, INTERMEDIATES, SIDE PRODUCTS AND DERIVATIVES MOEHLMAN, ANDREW TERRY —
18134929 FIELD SCANNING OPTICAL COHERENCE TOMOGRAPHY WRIGHT, ANDREW RUSSELL —

Top Art Units

Art UnitApps
1655 1
1662 1
2872 1
1631 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18888800 DIGITAL AUTOCORRELATOR LAMPRECHT, JOEL — §102§103§112 Non-Final OA — Pending Sep 18, 2024
18706982 METHODS FOR THE PRODUCTION OF TRYPTOPHANS, TRYPTAMINES, INTERMEDIATES, SIDE PRODUCTS AND DERIVATIVES MOEHLMAN, ANDREW TERRY 1655 §103§112 Non-Final OA — Pending May 02, 2024
18400586 COMPOSITIONS AND METHODS OF ENHANCING PHOTOSYNTHESIS CHATTERJEE, JAYANTA 1662 §103 Final Rejection 15d overdue Pending Dec 29, 2023
18134929 FIELD SCANNING OPTICAL COHERENCE TOMOGRAPHY WRIGHT, ANDREW RUSSELL 2872 §103 Non-Final OA — Pending Apr 14, 2023
18161467 CELLULAR REPROGRAMMING OF HUMAN ADIPOCYTES BATES, KEENAN ALEXANDER 1631 §102Other Non-Final OA 79d Pending Jan 30, 2023

Managing Miami University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month